SOBR Safe Inc
For the period ended Jun 30, 2024. Filed Aug 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 12, 2024
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2024-03-31; filed 2024-05-15.
0001477932-24-002962
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2024-06-30; filed 2024-08-12.
0001477932-24-004685
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 68 previous paragraphs and 91 current paragraphs.
41 unchanged; 17 reworded; 32 added; 9 removed; 1 previous and 1 current paragraphs rearranged.
Tables are not compared: 6 previous and 7 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (32)
Current report
The Company progressed to commercial production of its SOBRsure TM device in the third quarter of 2023 and began executing customer agreements. Revenues of $54,191 for the three-month period ended June 30, 2024, have increased by $16,590 as compared to the prior year period of $37,601. This increase is primarily driven by increased sales of our SOBRsure TM device of $21,993, offset by decreased sales of our SOBRcheck TMdevice of $2,163.
Current report
General and administrative expenses decreased by $503,450, from $1,899,383 for the three-month period ended June 30, 2023, to $1,395,933 for the three-month period ended June 30, 2024. This decrease is primarily attributable to a decrease in professional services spend by $317,188 a decrease in payroll costs by $88,125, and a decrease in travel expense by $41,172.
Current report
The Company had stock-based compensation expense of $185,910 for the three months ended June 30, 2024, compared to $627,762 for the three months ended June 30, 2023. The reduction in stock-based compensation expense is due to previously issued awards becoming fully vested and no issuance of new awards in 2024.
Current report
Research and development expenses increased by $115,252, to $308,427 for the three months ended June 30, 2024, compared to $193,175 for the three months ended June 30, 2023. The increase in research and development is due to the Company making improvements to its existing SOBRsafe™ software platform and other device functionality improvements.
Current report
Other Income, net
Current report
Other income, net decreased by $47,430 from $60,587 for the three months ended June 30, 2023 to $13,157 for the three months ended June 30, 2024. Other income consists primarily of interest income earned on cash deposits. The decrease is due to less cash on hand in 2024 when compared to 2023.
Current report
Gain (Loss) on Extinguishment of Debt, net
Current report
During the three months ended June 30, 2023, the Company recorded a loss on extinguishment of debt of $26,125 which related to the early payoff of convertible notes issued in 2021.
Current report
Interest expense was relatively consistent for the three-month periods ended June 30, 2024, and 2023, increasing by $4,171, from $209,125 for the three months ended June 30, 2023, to $213,296 for the three months ended June 30, 2024.
Current report
Our operating loss decreased by $822,060 from $2,699,295 for the three months ended June 30, 2023, to $1,877,235 for the three months ended June 30, 2024. The change in our operating loss for the three months ended June 30, 2024, compared to the same prior year period, is primarily a result in a reduction in general and administrative expense due to less spend on travel, professional services, and payroll. Stock-based compensation expense also decreased due to rewards fully vesting.
Current report
Our net loss decreased by $796,584 from $2,873,958 for the three-month period ended June 30, 2023, to $2,077,374 for the three-month period ended June 30, 2024. This change was primarily driven by a reduction in general and administrative expenses and stock-based compensation expense as detailed above. This has been slightly offset by a reduction in interest income as detailed above.
Current report
Results of Operations for Six Months Ended June 30, 2024 Compared to Six Months Ended June 30, 2023
Current report
Summary of Results of Operations
Current report
Revenue
Current report
The Company progressed to commercial production of its SOBRsure TM device in the third quarter of 2023 and began executing customer agreements. Revenues of $102,181 for the six-month period ended June 30, 2024, have increased by $16,712 as compared to the prior year period of $85,469. This increase is primarily driven by increased sales of our SOBRsure TM device of $35,257, offset by decreased sales of our SOBRcheck TMdevice of $13,458.
Current report
Gross Profit
Current report
The cost of goods and services for the six months ended June 30, 2024 was $65,937 resulting in a gross profit of $36,244 and a gross margin of 35%. The cost of goods and services for the six months ended June 30, 2023, was $46,640 resulting in a gross profit of $38,829 and a gross margin of 45%. The increased cost of goods and services for the period was due to one-time write-offs of defective SOBRcheck TM devices of $21,284. Without these one-time write-offs, the normalized gross margin would be 58%. Due to the limited history of generating revenue, the gross profit and gross margins for the six months ended June 30, 2024, and 2023 may not be indicative of future planned or actual performance of the Company, its product lines or services.
Current report
General and Administrative Expenses
Current report
General and administrative expenses decreased by $672,838, from $3,484,333 for the six-month period ended June 30, 2023, to $2,811,495 for the six-month period ended June 30, 2024. This decrease is primarily attributable to a decrease in professional services spend by $416,404 a decrease in payroll costs by $147,674, and a decrease in travel expense by $74,124.
Current report
Stock-Based Compensation Expense
Current report
The Company had stock-based compensation expense of $400,308 for the six months ended June 30, 2024, compared to $1,326,675 for the six months ended June 30, 2023. The reduction in stock-based compensation expense is due to previously issued awards becoming fully vested and no issuance of new awards in 2024.
Current report
Research and development expenses for the six months ended June 30, 2024, and 2023, increased by $36,368, from $374,093 for the six months ended June 30, 2023, to $410,461 for the six months ended June 30, 2024. The increase in research and development is due to the Company making improvements to its existing SOBRsafe™ software platform and other device functionality improvements.
Current report
Other Income, net
Current report
Other income, net decreased by $96,645 from $131,057 for the six months ended June 30, 2023 to $34,412 for the six months ended June 30, 2024. Other income consists primarily of interest income earned on cash deposits. The decrease is due to less cash on hand in 2024 when compared to 2023.
Current report
Gain (Loss) on Extinguishment of Debt, net
Current report
During the six months ended June 30, 2023, the Company recorded a loss on extinguishment of debt of $26,125 which related to the early payoff of convertible notes issued in 2021.
Current report
Notes Payable – Conversion Expense
Current report
Interest Expense
Current report
Interest expense was relatively consistent for the six-month periods ended June 30, 2024, and 2023, increasing by $11,502 from $434,310 for the six months ended June 30, 2023, to $445,812 for the six months ended June 30, 2024.
Current report
Operating Loss; Net Loss
Current report
Our net loss decreased by $892,355 from $5,475,650 for the six-month period ended June 30, 2023, compared to $4,583,295 for the six-month period ended June 30, 2024. The decrease in the operating loss of $1,560,252 for the six-month period ended June 30, 2024, from the prior year period was offset by a one-time expense incurred for notes payable conversion as well as a reduction in interest income as detailed above.
Current report
We received gross proceeds from the exercise of warrants of $2,786,174 during the six-month period ended June 30, 2024, which was offset by transactional costs of ($360,756).
Removed paragraphs (9)
Previous report
We progressed to commercial production, launch and sale of our first SOBRsure TM devices being delivered for use in October 2023, and our first SOBRcheck TM devices being delivered for use in January 2022. Both the SOBRcheck TM and SOBRsure TM devices are used in conjunction with our SOBRsafe TM software solution. We have executed customer agreements, invoiced customers and recognized revenue of $47,990 and $47,868 during the three-month periods ended March 31, 2024, and March 31, 2023.
Previous report
General and administrative expenses decreased by $169,388, from $1,584,950 for the three-month period ended March 31, 2023, to $1,415,562 for the three-month period ended March 31, 2024. The decrease from the same prior year period is primarily due to decreases in payroll expense as a result of our decreased employee base, a reduction in investor relations expense, offset by an increase in professional service fees.
Previous report
The Company had stock-based compensation expense of $214,398 for the three-months ended March 31, 2024, compared to $698,913 for the three-months ended March 31, 2023. The stock-based compensation expense was related to the issuance of our common stock or restricted stock units as compensation to certain consultants and employees that is recognized over the period of service.
Previous report
Research and Development
Previous report
Research and development expenses decreased by $78,884, to $102,034 for the three-months ended March 31, 2024, compared to $180,918 for the three-months ended March 31, 2023. The decrease in research and development was due to the final development stages of the SOBRcheck TM device which were completed in 2023, and the development of the SOBRsafe TM software platform which was completed in Q3 2023.
Previous report
Other Income (Expense), net
Previous report
Other income decreased by $49,215 to $21,255 for the three-months ended March 31, 2024, compared to $70,470 for the three-months ended March 31, 2023. The decrease is due to less interest earned in the Company’s money market account due to a lower cash balance in 2024.
Previous report
Interest expense increased by $7,331, from $225,185 for the three-month period ended March 31, 2023, to $232,516 for the three-month period ended March 31, 2024. This increase was due to make-whole interest related to the conversion of debt to common stock from outstanding convertible debt, offset by a decrease in overall interest expense on the remaining convertible debt post conversion.
Previous report
For additional information about our contractual commitments for these leases, see “Note 5 – Leases” included in our Notes to Consolidated Financial Statements.
Reworded paragraphs (17)
Previous wording
Our Management’s Discussion and Analysis or Plan of Operations contains not only statements that are historical facts, but also forward-looking statements within the meaning of the Exchange Act. Forward-looking statements include statements in which words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “consider,” or similar expressions are used. Forward-looking statements are, by their very nature, uncertain and risky. These risks and uncertainties include international, national and local general economic and market conditions; demographic changes; our access to capital to fund our continuing operations, our ability to sell our products and services and to sustain, manage, or forecast growth; our ability to successfully make and integrate acquisitions; raw material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to protect technology; and other risks that might be detailed from time to time in our filings with the Securities and Exchange Commission (“SEC”).
Current wording
Our Management’s Discussion and Analysis of financial condition and results of operations contains not only statements that are historical facts, but also statements that are forward-looking. Forward-looking statements are, by their very nature, uncertain and risky. These risks and uncertainties include international, national and local general economic and market conditions; demographic changes; our ability to sustain, manage, or forecast growth; our ability to successfully make and integrate acquisitions; raw material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to protect technology; and other risks that might be detailed from time to time in our filings with the Securities and Exchange Commission (“SEC”).
Previous wording
On March 9, 2020, our Board of Directors approved the amendment to our Certificate of Incorporation and stockholders holding 52% of our then outstanding voting stock approved an amendment to our Certificate of Incorporation. The Certificate of Amendment to our Certificate of Incorporation was for the purpose of, among other things, changing our name from “TransBiotec, Inc.” to “SOBR Safe, Inc.” The Certificate of Amendment to our Certificate of Incorporation became effective with the State of Delaware on April 24, 2020.
Current wording
On March 9, 2020, our Board of Directors approved the amendment to our Certificate of Incorporation and stockholders holding 52% of our then outstanding voting stock approved an amendment to our Articles of Incorporation. The Certificate of Amendment to our Certificate of Incorporation was for the purpose of, among other things, changing our name from “TransBiotec, Inc.” to “SOBR Safe, Inc.” The Certificate of Amendment to our Certificate of Incorporation became effective with the State of Delaware on April 24, 2020.
Previous wording
Our SOBRcheck™ device is a patent-pending, touch-based identity verification and alcohol detection solution. Users place two fingers on the device sensors for which one compares biometric data points from the finger to confirm identity, while the other senses alcohol released through the pores of the fingertip. The touch-based device connects to the SOBRsafe™ software solution to collect, present and communicate data collected to subscribed parties. The SOBRcheck™ device has been in commercial production since the first quarter of 2022 and we have executed customer agreements since that time.
Current wording
Our SOBRcheck™ device is a patent-pending, touch-based identity verification and alcohol detection solution. Users place two fingers on the device sensors, one compares biometric data points from the finger to confirm identity, while the other senses alcohol released through the pores of the fingertip. The touch-based device connects to the SOBRsafe™ software solution to collect, present and communicate data collected to subscribed parties. The SOBRcheck™ device has been in commercial production since the first quarter of 2022 and we have executed customer agreements since that time.
Previous wording
Since inception we have generated significant losses from operations and anticipate that we will continue to generate significant losses for the foreseeable future. Our success is dependent on our ability to access additional capital. Additional capital will be required under the following circumstances: 1) to offset negative cash flows from operations, 2) to accelerated customer acquisition, thereby increasing capital outlay, 3) for advanced purchasing of materials, 4) for the acquisition of new technology, 5) for potential acquisition of a key asset, and 6) for sales expansion.
Current wording
Since inception we have generated significant losses from operations and anticipate that we will continue to generate significant losses for the foreseeable future. Our success is dependent on our ability to access additional capital. Additional capital will be required under the following circumstances: 1) to offset negative cash flows from operations, 2) to accelerate customer acquisition, thereby increasing capital outlay, 3) for advanced purchasing of materials, 4) for the acquisition of new technology, 5) for potential acquisition of a key asset, and 6) for sales expansion.
Previous wording
During the quarter ended March 31, 2024, the following developments occurred:
Current wording
During the six-months ended June 30, 2024, the following developments occurred:
Previous wording
The cost of sales for the three-months ended March 31, 2024, was $24,781 resulting in a gross profit of $23,209 and a gross margin of 48.4%. The cost of sales for the three-months ended March 31, 2023, was $30,064 resulting in a gross profit of $17,804 and a gross margin of 37.2%. Due to the limited history of generating revenue, the gross profit and gross margins at March 31, 2024 and 2023 are not indicative of future planned or actual performance of the Company, its product lines or services.
Current wording
The cost of goods and services for the three months ended June 30, 2024, was $41,156 resulting in a gross profit of $13,035 and a gross margin of 24%. The increased cost of goods and services for the period was due to one-time write-offs of defective SOBRcheck TM devices of $17,434. Without these one-time write-offs, the normalized gross margin would be 56%. Due to the limited history of generating revenue, the gross profit and gross margin for the three months ended June 30, 2024, and 2023 may not be indicative of future planned or actual performance of the Company, its product lines or services.
Previous wording
Conversion expense was $585,875 for the three-months ended March 31, 2024. This expense relates to the convertible debt inducement that occurred on March 4, 2024. There was no conversion expense for the three-months ended March 31, 2023.
Current wording
Notes payable conversion expense was $585,875 for the six months ended June 30, 2024. This expense relates to the convertible debt inducement that occurred on March 4, 2024.
Previous wording
Our net loss decreased by $95,771 from $2,601,692 to $2,505,921, from the three-month period ended March 31, 2023, compared to the three-month period ended March 31, 2024. The change in our net loss and operating loss for the three months ended March 31, 2024, compared to the same prior year period, is primarily a result of a decrease in stock-based compensation expense and a decrease in investor relations spend, offset by notes payable conversion expense. The changes are detailed below.
Current wording
Our operating loss decreased by $1,560,252 from $5,146,272 for the six-month period ended June 30, 2023, compared to $3,586,020 for the six-month period ended June 30, 2024. The change in our operating loss for the six months ended June 30, 2024, compared to the same prior year period, is primarily a result in a reduction in general and administrative expense due to less spend on travel, professional services, and payroll. Stock-based compensation expense also decreased due to rewards fully vesting.
Previous wording
Liquidity and Capital Resources for Three Months Ended March 31, 2024 Compared to December 31, 2023
Current wording
Liquidity and Capital Resources for Six Months Ended June 30, 2024 Compared to December 31, 2023
Previous wording
During the three-months ended March 31, 2024 and 2023, the Company has incurred recurring losses from operations. Future capital requirements will depend on many factors including the Company’s ability to sell and develop products, generate cash flow from operations, and assess competing market developments. The Company will need additional capital in the near term. Our cash on hand as of March 31, 2024, was $1,336,250 and our current normalized operating cash flow burn rate is approximately $475,000 per month.
Current wording
During the six-months ended June 30, 2024, and 2023, the Company has incurred recurring losses from operations. Future capital requirements will depend on many factors including the Company’s ability to sell and develop products, generate cash flow from operations, and assess competing market developments. The Company will need additional capital in the near term. Our cash on hand as of June 30, 2024, was $2,166,404 and our current normalized operating cash flow burn rate is approximately $475,000 per month.
Previous wording
Management believes that cash balances and negative working capital at March 31, 2024 do not provide adequate operating capital for operating activities for the twelve months from the date these financial statements are issued. However, management believes actions presently being taken to generate product and services revenues, and positive cash flows, in addition to the Company’s plans and ability to access capital sources and implement additional expense reduction tactics to preserve working capital, provide the opportunity for the Company to continue as a going concern. These plans are contingent upon the actions to be performed by the Company and these conditions have not been met on or before March 31, 2024. As such, substantial doubt about the entity’s ability to continue as a going concern has not been alleviated as of March 31, 2024.
Current wording
Management believes that cash balances at June 30, 2024 do not provide adequate operating capital for operating activities for the twelve months from the date these financial statements are issued. However, management believes actions presently being taken to generate product and services revenues, and positive cash flows, in addition to the Company’s plans and ability to access capital sources and implement additional expense reduction tactics to preserve working capital, provide the opportunity for the Company to continue as a going concern. These plans are contingent upon the actions to be performed by the Company and these conditions have not been met on or before June 30, 2024. As such, substantial doubt about the entity’s ability to continue as a going concern has not been alleviated as of June 30, 2024.
Previous wording
Our cash, total current assets, total assets, total current liabilities, and total liabilities as of March 31, 2024, and as of December 31, 2023, respectively, are as follows:
Current wording
Our cash, current assets, total assets, current liabilities, and total liabilities as of June 30, 2024, and as of December 31, 2023, respectively, are as follows:
Previous wording
Our total current liabilities increased as of March 31, 2024, as compared to December 31, 2023. The increase was due to the classification of convertible debt which is due in March 2025.
Current wording
Our total current liabilities and total liabilities decreased as of June 30, 2024, as compared to December 31, 2023. The decrease was due to the conversion of the entire convertible debt balance due in March 2025 to equity during the quarter.
Previous wording
We had net cash used in operating activities of $1,453,897 for the three-month period ended March 31, 2024, as compared to net cash used for operating activities of $1,589,453 for the three-month period ended March 31, 2023. For the period in 2024, the net cash used in operating activities consisted primarily of our net loss of $2,505,921, offset by non-cash expense items including amortization of $96,366, amortization of debt discounts of $149,295, stock-based compensation expense of $214,398, interest expense of $80,784 conversion expense of $585,875, and changes in our assets and liabilities primarily from inventory of $22,179, prepaid expenses of $14,808, other assets of ($15,300), accounts payable of $107,073, accrued expenses of $(204,486), and accrued interest payable of $2,171.
Current wording
We had net cash used in operating activities of $3,049,161 for the six-month period ended June 30, 2024, as compared to net cash used in operating activities of $3,262,642 for the six-month period ended June 30, 2023. For the period in 2024, the net cash used in operating activities consisted primarily of our net loss of $4,583,295, offset by non-cash expense items including amortization of $192,732, amortization of debt discounts of $237,250, stock-based compensation expense of $400,307, non-cash interest expense of $336,510, non-cash lease expense of $44,284, non-cash conversion expense of $585,875 and changes in our assets and liabilities for accounts receivable of ($9,708), inventory of $60,844, prepaid expenses of $81,051, accrued expenses of ($208,212), accrued interest payable of ($128,214), and operating lease liabilities of ($46,872).
Previous wording
For the period in 2023, the net cash used in operating activities consisted primarily of our net loss of $2,601,692, offset primarily by non-cash expense items including amortization of $96,366, amortization of interest of $21,644, stock warrants expense of $134,598, and stock-based compensation expense of $698,913, bad debt expense of $882 and changes in our assets and liabilities primarily from inventory of ($34,239), prepaid expenses of $162,477, accounts payable of $198,159, accrued expenses of $(87,986), and accrued interest payable of $(177,927).
Current wording
For the period in 2023, the net cash used in operating activities consisted primarily of our net loss of $5,475,650, offset by non-cash expense items including amortization of $192,732, amortization of interest of $286,346, loss on extinguishment of debt of $26,125, stock warrants expense of $182,901, stock-based compensation expense of $1,326,675, non-cash interest expense of $29,638, non-cash lease expense of $13,747, bad debt expense of $1,132 and changes in our assets and liabilities for accounts receivable of ($1,938), inventory of ($47,867), prepaid expenses of $398,521, other assets of ($15,931), accounts payable of $341,425, accrued expenses of $1,185, accrued interest payable of $(324,083), and operating lease liabilities of ($14,699).
Previous wording
We had no cash provided by or used in investing activities during the three-month periods ended March 31, 2024 or March 31, 2023.
Current wording
We had no cash provided by or used in investing activities during the six-month periods ended June 30, 2024, or June 30, 2023.
Previous wording
During the three-month period ended March 31, 2023, we received gross proceeds from the issuance of convertible notes payable of $3,000,001 which was offset by issuance costs of $537,750. Payments of approximately $1,161,792 were made toward the principal and accrued interest amounts for matured convertible notes payable issued in 2021 to both related and non-related parties.
Current wording
During the six-month period ended June 30, 2023, we received gross proceeds from the issuance of convertible notes payable of $3,000,001 which was offset by issuance costs of $537,750. Payments of approximately $2,100,000 were made toward the principal and accrued interest amounts for matured convertible notes payable issued in 2021 to both related and non-related parties.
Rearranged current paragraphs (1)
Current report — wording carried from elsewhere
The Company had no notes payable conversion expense for the three months ended June 30, 2024.
Rearranged previous paragraphs (1)
Previous report — wording carried elsewhere
We had no cash provided by or used in financing activities during the three-month period ended March 31, 2024.